Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Boston Scientific Corporation : BSX, ABT, ZMH, and ETRM Under StockCall’s Microscope

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/02/2013 | 02:00pm CEST

StockCall.com Provides Stock Research on Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc.

New York City, New York -- (May 02, 2013)

The Supreme Court, last year, upheld the Affordable Care Act (ACA), which is the biggest overhaul of the healthcare industry in decades. While the healthcare industry has generally supported ACA, some features of the act have faced criticism. One such feature is the 2.3% tax on gross U.S. sales of medical devices. Medical appliances & equipment makers say that the tax will lead to higher costs for them, hurting innovation. While the Senate voted in favor of repealing the 2.3% tax, it is unlikely that the tax will be repealed. Shares of medical appliances & equipment companies ended mostly lower on Wednesday, tracking losses in the broad market. Among the major movers were Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM). StockCall has released full comprehensive research on BSX, ABT, ZMH, and ETRM and these free technical analyses can be downloaded by signing up at

www.stockcall.com/technicalanalysis

Shares of Boston Scientific Corporation fluctuated between gains and losses on Wednesday before finishing the day flat at $7.49 on volume of 12.95 million. Shares of the company have traded sideways this week. However, year-to-date, the stock has had an excellent run, jumping more than 30.70% as compared to a gain of nearly 11% for the S&P 500. BSX?s shares are currently trading nearly 5.80% below their 52-week high. Free technical analysis on BSX available by signing up at

www.StockCall.com/BSX050213.pdf

Shares of Abbott Laboratories edged lower in Wednesday?s trading session, however, the losses were limited. The stock ended the day 0.08% lower at $36.89 on volume of 5.46 million after trading between $36.62 and $37.20. Despite the pullback, Abbott?s shares are up nearly 1.20% for the week. The stock has gained more than 18.50% so far in 2013, outperforming the S&P 500. However, shares of ABT have been struggling to break through $37.50 resistance level. The stock is currently trading well above its 50-day and 200-day moving averages. Register today and access the free research on ABT at

www.StockCall.com/ABT050213.pdf

Zimmer Holdings Inc.?s shares also slipped in trading on Wednesday, tracking losses in the broad market. The stock closed 1.50% lower at $75.30 on volume of 617,800. Despite the pullback, the company?s shares are currently trading close to their 52-week high of $77.53. Shares of ZMH have been facing resistance at around $76.50. The stock currently has strong support at around $73. Zimmer?s shares are currently trading well above their 50-day and 200-day moving averages which suggests that market sentiment is bullish on the stock. The positive trend is further confirmed by recent volume activity. The free report on ZMH can be downloaded by signing up now at

www.StockCall.com/ZMH050213.pdf

Shares of EnteroMedics Inc. tumbled in Wednesday?s trading session after the company reported its financial results for the first quarter. The stock closed 9.59% lower at $0.868 on above average volume of 601,300 after touching an intra-day low of $0.86. Shares of ETRM are currently trading close to their 52-week low of $0.81. Year-to-date, the stock has now fallen nearly 69%. Most of the losses came in mid-February when the stock saw a huge sell-off. EnteroMedics? shares have now slipped below their 50-day moving average. Free report on ETRM can be accessed by registering at

www.StockCall.com/ETRM050213.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

www.stockcall.com

Contact Person:

William T. Knight

Email: info@stockcall.com

Contact Number: (646) 396-9857 (9:00 am EST ? 01:30 pm EST)


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BOSTON SCIENTIFIC CORPORAT
07/20 BOSTON SCIENTIFIC : Patent Issued for Multi-Component Particles for Injection an..
07/20 Abbott profit forecast gets a lift from St. Jude integration
07/17 BOSTON SCIENTIFIC : Appeals Court reverses, remands noncompete ruling
07/10 NITINOL MEDICAL DEVICE MARKET SIZE I : Crystal Market Research
07/08 BOSTON SCIENTIFIC : A Modern-Day Approach to Better Diversity Outcomes
07/08 Global Diaphragm Pacing Device Market 2017 - Medtronic, Boston Scientific, St..
07/06 STUDY RESULTS FROM BOSTON SCIENTIFIC : YAG laser...
07/06 MEDTRONIC : Global Cardiac Pacing Sales Market 2017 - Shree Pacetronix, Biotroni..
07/06 MEDTRONIC : Global Tissue Engineered Heart Valve Sales Market 2017 - Boston Scie..
07/05 BOSTON SCIENTIFIC : to Webcast Conference Call Discussing Second Quarter 2017 Fi..
More news
News from SeekingAlpha
06/28 Boston Scientific Corporation (BSX) Investor Presentation - Slideshow
06/27 Boston Scientific hosts Investor Day today; goal of 6-8% organic annual reven..
06/24 Stocks to watch next week
06/09 WEAR ETF (WEAR) May Summary
06/06 Boston Sci's Gevia DBS System CE Mark'd
Financials ($)
Sales 2017 8 876 M
EBIT 2017 2 097 M
Net income 2017 1 338 M
Debt 2017 4 534 M
Yield 2017 -
P/E ratio 2017 29,92
P/E ratio 2018 25,94
EV / Sales 2017 4,79x
EV / Sales 2018 4,34x
Capitalization 37 974 M
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Technical analysis trends BOSTON SCIENTIFIC CORPORAT
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 30,5 $
Spread / Average Target 9,8%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian Meredith Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION27.69%37 974
THERMO FISHER SCIENTIFIC INC.29.11%71 026
DANAHER6.69%58 944
INTUITIVE SURGICAL46.25%35 799
ROYAL PHILIPS6.86%34 313
ILLUMINA34.92%25 159